PER 1.25% 8.1¢ percheron therapeutics limited

antisense drugs pass and approved!!, page-57

  1. 655 Posts.
    lightbulb Created with Sketch. 47
    * Note: The Company believes there is a reasonable expectation of receiving an R&D tax offset cash
    inflow from the ATO of approximately $370k during the 2nd quarter (Oct – Dec 2011).
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
0.001(1.25%)
Mkt cap ! $72.57M
Open High Low Value Volume
8.0¢ 8.1¢ 8.0¢ $205.0K 2.546M

Buyers (Bids)

No. Vol. Price($)
2 164999 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 300671 2
View Market Depth
Last trade - 14.45pm 26/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.